SHH · Key Statistics

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) Key Statistics

$16.54 SHH: 601607.SS Market Cap $61.19B

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	12.79
P/B ratioShare price divided by book value per share.	0.78
P/S ratioMarket value divided by annual revenue.	0.21

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	10.92%
Operating marginRevenue left after operating costs.	3.56%
Net marginRevenue left after every cost, including tax and interest.	1.65%
Return on equityProfit as a percentage of shareholders’ equity.	6.96%
Return on assetsProfit as a percentage of total assets.	2.34%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	1.34
Quick ratioThe same, excluding inventory.	1.01
Debt to equityTotal borrowings against shareholders’ equity.	0.63

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$1.29
Book value per shareShareholders’ equity divided by shares outstanding.	$21.13
Shares outstandingShares currently issued.	2,789,289,105
Market capitalisationShare price times shares outstanding.	$61.19B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$0
EmployeesReported headcount.	48,640

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	2.69%
Payout ratioShare of profit paid out as dividends.	34.41%

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) statistics — frequently asked questions

What is Shanghai Pharmaceuticals Holding Co., Ltd's P/E ratio?

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) trades on a price-to-earnings ratio of 12.79.

What is Shanghai Pharmaceuticals Holding Co., Ltd's return on equity?

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) reports a return on equity of 6.96%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Shanghai Pharmaceuticals Holding Co., Ltd carry?

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) has a debt-to-equity ratio of 0.63, which compares total borrowings with shareholders' equity.

What is Shanghai Pharmaceuticals Holding Co., Ltd's profit margin?

Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) keeps 1.65% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.